Logo KMS TEAM
Precise execution

MC Services is...

Client News

… an international Corporate Communications and Investor Relations firm providing high-level consultancy with targeted services and support for transaction-oriented assignments throughout Europe and the United States.

read more

MC Services at analytica in Munich on April 03, 2014 (FINANCE DAY)

MC Services, the international Investor Relations and Public Relations Company, hosted a booth at this year’s analytica meeting, the leading trade fair for modern laboratory technology and biotechnology. Our focus this year was on the FINANCE DAY on April 03, 2014, in which also some of our clients participated in panel sessions.

read more

MC Services one of the main sponsors of the 7th DVFA Life Science Conference 2014

This year MC Services acts as one of the main sponsors of the 7th DVFA Life Science Conference, which will take place in Frankfurt on May 07, 2014. Over recent years the DVFA Life Science Conference has become a highly valued platform to discuss new innovative technologies, therapies and products with financial market participants.

The conference focuses on innovative treatment strategies for cancer, an area where MC Services’ clients have taken leading roles.

read more

 

 

BioCrea Provides Update on Development Programs for Partners

www.biocrea.com

GBC Research reiterates 'BUY' recommendation on SYGNIS AG with a price target of EUR6.00

www.sygnis.com

4SC Discovery receives EU grant worth EUR 450,000 for the research of new epigenetic compounds against stroke

www.4sc.de

WILEX publishes 3-month Financial Report 2014

www.wilex.de

Affimed Highlights Further Data on AFM13, a Bispecific CD30/CD16A TandAb in Development to Treat Hodgkin Lymphoma, at the 2014 AACR Annual Meeting

www.affimed.de

AbCheck Antibody Discovery Deal with Pierre Fabre

www.abcheck.eu

CetuGEX(TM) demonstrates enhanced anti-tumor activities, reduced side effects and a broader patient and indication range

www.glycotope.com

Alacris Theranostics ModCellTM system will use the SAP HANA(R) platform to speed up in silico modeling of drug responses during patient treatments as well as for drug development and approval

www.alacris.de

SYGNIS reports financial results for a successful fiscal year 2013

www.sygnis.com

MagForce AG publishes Shareholder Letter

www.magforce.com

MorphoSys präsentiert auf zwei anstehenden Investorenkonferenzen

www.morphosys.de

Enrollment of the first patient in the MF 1001 glioblastoma study at the Muenster University Clinic

www.magforce.com